UCB SA (UNC BE) stock market data APIs
€252.5731
5.34(2.1%)
as of March 18, 2026
Try our APIs with
free plan!
UCB SA Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for UNC.BE.
Prev. Close
252.5731
Open
257.9135
High
260.6869
Low
249.9408
52 wk Range
134.6088-268
Market Cap
18 821 M
Dividends (Yield)
0.0149
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get UCB SA data using free add-ons & libraries
Get UCB SA Fundamental Data
UCB SA Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
UCB SA News
New
UCB (ENXTBR:UCB): A Fresh Look at Valuation as Momentum Builds
UCB (ENXTBR:UCB) shares have caught more attention lately thanks to a mix of solid recent performance and strong momentum over the past month. Investors are watching closely to see if this trend conti...
UCB Soars to Record as Rival MoonLake Crashes on Trial Data
(Bloomberg) -- Shares in Belgium’s UCB SA soared to a record, while rival MoonLake Immunotherapeutics is set to lose most of its value, after the latter announced late-stage trial data for an experi...
Recent Price Trend in UCB (UCBJY) is Your Friend, Here's Why
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a tren...
Europe Refractory Epilepsy Treatment Research Report 2025 | Market to More Than Double to Reach $2.82 Billion by 2035, Driven by CBD Growth, Uptake of Neuromodulation Therapies, Strong R&D Pipeline
Company Logo The Europe refractory epilepsy treatment market is anticipated to grow from $1.34 billion in 2024 to $2.82 billion by 2035, with a CAGR of 6.98% from 2025 to 2035. This shift towards per...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
